Emergent BioSolutions Inc.
EBSNYSECIK 1367644HealthcareFiscal year ends Dec 31
Reports and events: 405 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-08-2016:20 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-24-000152 |
| 2024-08-0717:37 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001367644-24-000147 |
| 2024-08-0616:21 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-24-000142 |
| 2024-07-3108:56 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-24-000134 |
| 2024-07-3016:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001367644-24-000130 |
| 2024-07-1216:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001367644-24-000125 |
| 2024-07-0816:57 ET | 8-K | 8.01 Other events | 0001367644-24-000118 |
| 2024-07-0208:19 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-24-000116 |
| 2024-06-2007:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-24-000112 |
| 2024-05-2907:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-24-000093 |
| 2024-05-0217:38 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001367644-24-000063 |
| 2024-05-0116:44 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-24-000060 |
| 2024-05-0116:05 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-24-000058 |
| 2024-04-3017:22 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001367644-24-000055 |
| 2024-04-2616:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001367644-24-000053 |
| 2024-04-1117:26 ET | DEF 14A | Proxy statementPeriod 2024-05-23 | 0001193125-24-093400 |
| 2024-03-0816:21 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001367644-24-000033 |
| 2024-03-0616:15 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-24-000026 |
| 2024-02-2107:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-24-000006 |
| 2024-01-1107:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-24-000004 |
| 2024-01-0908:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-24-000002 |
| 2023-12-1107:24 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001367644-23-000208 |
| 2023-12-1107:17 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001367644-23-000207 |
| 2023-11-2807:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-23-000199 |
| 2023-11-2407:17 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001367644-23-000195 |
| 2023-11-1616:11 ET | 8-K | 4.02 Non-reliance on financial statements | 0001367644-23-000193 |
| 2023-11-0816:21 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000182 |
| 2023-10-0507:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-23-000169 |
| 2023-10-0207:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000166 |
| 2023-08-3006:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-23-000163 |
| 2023-08-1616:47 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000160 |
| 2023-08-0918:42 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001367644-23-000155 |
| 2023-08-0816:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000152 |
| 2023-08-0807:15 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001367644-23-000148 |
| 2023-07-3116:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001367644-23-000144 |
| 2023-07-2716:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001367644-23-000142 |
| 2023-07-2108:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000135 |
| 2023-06-2707:54 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000127 |
| 2023-05-3117:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000112 |
| 2023-05-3007:32 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000094 |
| 2023-05-1821:32 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-147301 |
| 2023-05-1508:01 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000091 |
| 2023-05-1017:51 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001367644-23-000088 |
| 2023-05-0916:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000087 |
| 2023-04-1707:46 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000082 |
| 2023-04-1416:13 ET | DEF 14A | Proxy statement | 0001193125-23-102074 |
| 2023-03-2909:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000077 |
| 2023-03-2317:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000075 |
| 2023-03-0116:18 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001367644-23-000046 |
| 2023-02-2716:46 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001367644-23-000024 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.